Omega Diagnostics Group PLC - Alva, Scotland-based diagnostics company - Expects to report revenue of GBP12.3 million for the year ended March 31, up 41% from GBP8.7 million the year before. Says Covid-19-related revenue grew 53% to GBP2.6 million from GBP1.7 million. Expects ongoing Covid-related income to be minimal. Notes that net cash balance was GBP1.5 million at year-end and that it has an overdraft facility of GBP2.0 million which remains in place and unutilised. Continues to actively explore alternative options to generate additional funds.
Current stock price: 5.28 pence; down 5.7% on Thursday
Year-to-date change: down 94%
By Abby Amoakuh; abbyamoakuh@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
